Multiepitope Vaccines against Neglected, Emerging, and Re-emerging Global Diseases
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 2275
Special Issue Editor
2. Institute for Liberal Arts and Sciences, Kyoto University, Kyoto, Japan
Interests: protein engineering; protein biochemistry; computational modeling; neglected tropical diseases; host–pathogen interactions; protein expression and purification; structural biology; nanobodies; therapeutics discovery
Special Issue Information
Dear Colleagues,
Neglected Global Diseases are infectious diseases and other conditions that cause physical and cognitive impairments, including maternal, infant and child health conditions; neglected tropical diseases; as well as malaria, tuberculosis, and HIV/AIDS. As climate change pushes the natural selection of pathogens and their vectors and natural reservoirs, the risk of these neglected diseases emerging within a larger global population poses an even greater threat. Vaccination is still viewed as the most effective method of preventing these infectious diseases by inducing protective immunity. Reverse vaccinology and immunoinformatics approaches have improved vaccine development and enabled the rapid identification of putative vaccine antigens by screening genomes and/or proteomes; in turn, they have led to the generation of multiepitope vaccines with superior effectiveness. This vaccine platform comprises short immunogenic determinants rather than an entire protein to elicit cellular and humoral immune responses, inducing long-term protection. Such a platform is extremely advantageous due to its safety, rapid production (unlike the traditional vaccines), and low cost; moreover, it has already been utilized in numerous vaccine design studies, generating promising results for several target pathogens, such as dengue virus, Trypanosoma cruzi, Ebola virus, Schistosoma, and SARS cov-2 virus, among several others.
This Special Issue invites articles and reviews involving multiepitope vaccine design against neglected, emerging, and re-emerging global diseases, as well as methodologies, novel evaluation, and prediction tools for vaccine design improvement. This issue also welcomes works involving the recombinant production and in vitro and/or in vivo validation of these chimeric vaccines.
Dr. Cerrone Cabanos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunoinformatics
- structure-based
- reverse vaccinology
- multiepitope
- mRNA
- vaccines
- glycosylation
- disulfide-engineering
- recombinant production
- modeling
- pathogens
- neglected global diseases
- molecular dynamics
- immune simulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
